R
The startup develops and evaluates novel pharmaceuticals targeting cancer and immunology, facilitating global licensing agreements to enhance treatment options. By providing healthcare companies with new therapeutic pathways, the company aims to improve patient outcomes and promote healthier lives.
Daejeon, South Korea
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops and evaluates novel pharmaceuticals targeting cancer and immunology, facilitating global licensing agreements to enhance treatment options. By providing healthcare companies with new therapeutic pathways, the company aims to improve patient outcomes and promote healthier lives.